Orai1 promotes tumor progression by enhancing cancer stemness via NFAT signaling in oral/oropharyngeal squamous cell carcinoma

• Published in: Oncotarget Vol. 7; no. 28; pp. 43239 - 43255
• Main Authors: Lee, Sung Hee, Rigas, Nicole Kristina, Lee, Chang-Ryul, Bang, April, Srikanth, Sonal, Gwack, Yousang, Kang, Mo K, Kim, Reuben H, Park, No-Hee, Shin, Ki-Hyuk
• Format: Journal Article
• Language: English
• Published: United States Impact Journals LLC 12.07.2016
• Subjects: Animals; Carcinogenesis - metabolism; Carcinoma, Squamous Cell - pathology; Cell Line, Tumor; Cell Movement; Disease Progression; Humans; Immunohistochemistry; Isoenzymes - metabolism; Keratinocytes; Mice; Mice, Nude; Microscopy, Confocal; Mouth Neoplasms - pathology; Mutation; Neoplastic Stem Cells - metabolism; Neoplastic Stem Cells - pathology; NFATC Transcription Factors - genetics; NFATC Transcription Factors - metabolism; ORAI1 Protein - genetics; ORAI1 Protein - metabolism; Oropharyngeal Neoplasms - pathology; Research Paper; Retinal Dehydrogenase - metabolism; RNA Interference; RNA, Small Interfering - metabolism; Signal Transduction; Spheroids, Cellular; Xenograft Model Antitumor Assays; Orai1; SOCE; OSCC; cancer stem cells; NFAT
• ISSN: 1949-2553; 1949-2553
• DOI: 10.18632/oncotarget.9755

Emerging evidence indicates that Orai1, a key calcium channel for store-operated Ca2+ entry, is associated with human cancer. However, the underlying mechanism by which Orai1 regulates cancer progression remains unknown. Here we report that intracellular level of Orai1 is increased in a stepwise manner during oral/oropharyngeal carcinogenesis and highly expressed in cancer stem-like cell (CSC)-enriched populations of human oral/oropharyngeal squamous cell carcinoma (OSCC). Ectopic Orai1 expression converted non-tumorigenic immortalized oral epithelial cells to malignant cells that showed CSC properties, e.g., self-renewal capacity, increased ALDH1HIGH cell population, increased key stemness transcription factors, and enhanced mobility. Conversely, inhibition of Orai1 suppressed tumorigenicity and CSC phenotype of OSCC, indicating that Orai1 could be an important element for tumorigenicity and stemness of OSCC. Mechanistically, Orai1 activates its major downstream effector molecule, NFATc3. Knockdown of NFATc3 in the Orai1-overexpressing oral epithelial cells abrogates the effect of Orai1 on CSC phenotype. Moreover, antagonist of NFAT signaling also decreases CSC phenotype, implying the functional importance of Orai1/NFAT axis in OSCC CSC regulation. Our study identifies Orai1 as a novel molecular determinant for OSCC progression by enhancing cancer stemness, suggesting that inhibition of Orai1 signaling may offer an effective therapeutic modality against OSCC.